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Most strains of Staphylococcus aureus and Staphylococcus epidermidis possess a strong
restriction barrier that hinders exchange of DNA. Recently, major advances have been
made in identifying and characterizing the restriction-modification (RM) systems involved.
In particular a novel type IV restriction enzyme that recognizes cytosine methylated DNA
has been shown to be the major barrier to transfer of plasmid DNA from Escherichia
coli into S. aureus and S. epidermidis. While the conserved type I RM system provides
a further barrier. Here we review the recent advances in understanding of restriction
systems in staphylococci and highlight how this has been exploited to improve our ability
to manipulate genetically previously untransformable strains.
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INTRODUCTION
The principles behind the use of genetic manipulation to iden-
tify virulence factors in pathogenic bacteria were articulated by
Stanley Falkow as Molecular Koch’s Postulates (Falkow, 1988).
The basic premise is that by using precise genetic manipulation,
the genes encoding putative virulence factors can be inactivated
and the mutants tested for loss of virulence in infection models.
It is also necessary to demonstrate that complementation restores
virulence to wild-type levels. As pointed out by Falkow, “these
postulates place a heavy burden on an investigator. They insist
that genetic manipulation of the microorganism is a prerequisite
for success, and, of course, for some pathogens, such study is not
yet possible.” (Falkow, 1988).
A major barrier to the genetic manipulation of staphylococci
and fulfilling Molecular Koch’s Postulates is the inability to trans-
form plasmid DNA into the majority of clinical isolates due to a
strong restriction-modification (RM) barrier. Consequently stud-
ies have focused on a small number of transformable laboratory
strains of S. aureus (Voyich et al., 2005; Baba et al., 2008; O’Neill,
2010) and S. epidermidis (Heilmann et al., 1996). In this review
we will focus on the recent developments in the understanding of
RM systems in staphylococci and will show how these findings,
combined with the development of new tools for genetic analysis,
have advanced our ability to manipulate staphylococci genetically.
RM SYSTEMS OF STAPHYLOCOCCI—A HISTORICAL
OVERVIEW
Four different types of RM systems are known but only three are
found in staphylococci. Type I RM systems comprise genes that
encode a host specificity of DNA (hsd) specificity (S) protein,
a modification (M) protein and a restriction (R) endonucle-
ase (Murray, 2000). HsdS functions in an HsdS1HsdM2 com-
plex which recognizes a specific DNA sequence. The complex
methylates hemi-methylated DNA and inhibits cleavage by the
endonuclease complex HsdS1HsdM2HsdR2 which would other-
wise assemble on unmethylated DNA (Murray, 2000). Cleavage
of unmodified DNA occurs after HsdR-dependent translocation
of the complex along the molecule until it collides with a second
complex (or DNA secondary structure), which stimulates the for-
mation of double stranded DNA breaks (Simons and Szczelkun,
2011). Type II RM systems are well known to molecular biol-
ogists because the restriction endonucleases are widely used as
reagents in molecular biology. The cleavage of DNA is sequence-
dependent and can be prevented by the DNA methylation status.
In S. aureus the Sau3AI type II RM system is present in a lim-
ited subset of strains (Stobberingh et al., 1977). The type IV
system is the simplest form of restriction system with a single pro-
tein able to detect the methylation status. Examples from E. coli
are mcrA, mcrBC which recognize 5-hydroxymethylcytosine and
N-4-methylcytosine, respectively, while and mrr recognizes N-
6-methyladenine as foreign. DNA containing these motifs are
restricted by the corresponding enzyme (Kelleher and Raleigh,
1991).
Over 50 years have passed since RM was first recognized in
S. aureus. In early phage typing studies it was observed that some
strains were resistant to infection by phage. However, a strain
could be infected if a high phage titer was used (Roundtree, 1956)
or the recipient was heat-shocked beforehand (Asheshov and
Jevons, 1963), suggesting that the barrier to infection could be
overwhelmed or by-passed by transient inactivation. Restriction-
deficient mutants of the clonal complex (CC—lineages derived
from multi locus sequence typing) (Enright et al., 2000) 8
strain 8325 (SA113) (Iordanescu and Surdeanu, 1976) and the
CC51 strain 879 (879R4) (Stobberingh and Winkler, 1977) were
isolated which could take up foreign DNA and modify it so that
it could be transferred to closely related wild-type strains. Both
strains are thus r−m+, i.e., defective in restricting foreign DNA
but capable of modifying the newly introduced DNA.
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In order to facilitate genetic manipulation of S. aureus it is
necessary to be able to transform S. aureus with shuttle plasmids
that have been constructed in E. coli. Strain 8325-4 (8325 cured
of three prophages) was subjected to heavy chemical mutagenesis
and then transformed by protoplast transformation with a shut-
tle plasmid isolated from E. coli in order to isolate a mutant that
could accept foreign DNA (Kreiswirth et al., 1983). From these
experiments a single transformant was obtained. The plasmid was
eliminated and then the S. aureus clone shown to accept the E. coli
isolated plasmid at a reasonable frequency. This strain, called
RN4220, has been extensively used by staphylococcal researchers
ever since. However, it only provides a gateway into a limited set
of closely related strains, e.g., in our hands 8325-4 isolated plas-
mid cannot transform MRSA252 (CC30) and vice versa. Also we
cannot transform S. epidermidis isolates tested (RP62a or AMC5)
with RN4220 isolated plasmid (unpublished data). The genome
sequence of RN4220 revealed a nonsense mutation in the hsdR
gene of a type I RM system among the 110 single nucleotide poly-
morphisms by which it differs from the parental strain (Nair et al.,
2011). It had been previously shown by Waldron and Lindsay
(Waldron and Lindsay, 2006) that complementation of RN4220
mutant hsdR allele with wild-type hsdR expressed from a low
copy number plasmid prevented transformation by electropora-
tion with a shuttle plasmid isolated from E. coli K-12, inhibited
transduction and reduced the frequency of conjugation of a plas-
mid from Enterococcus faecalis. However Veiga and Pinho (2009)
were unable to confirm the role of HsdR as the barrier to uptake
of foreign DNA when they deleted hsdR in 8325-4 and COL.
Mild heat shock (56◦C for 2min) prior to electroporation allowed
transformation of 8325-4hsdR but not the parental 8325-4.
These results suggested that an additional heat-sensitive restric-
tion system prevented transformation with plasmid DNA from
E. coli K-12 (Veiga and Pinho, 2009). Interestingly, the major-
ity of sequenced S. aureus isolates contain 2 sets of hsdMS genes
located on the alpha and beta pathogenicity islands (Waldron and
Lindsay, 2006), with hsdR located at a third site on the chromo-
some. This is in direct contrast to S. epidermidis and S. lugdunensis
where the type I RM genes are clustered together (unpublished
observation). In some MRSA strains, a third complete hsdMSR
has also been identified in the staphylococcal cassette chromo-
some mec element (SCCmec) III, with hsdMR found in the
SCCmec VII (Malachowa and DeLeo, 2010). The functionality of
the modification and specificity genes in staphylococci has not
been published. In S. aureus the sequences of the hsdM genes
are highly conserved, while the two hsdS genes are divergent
(Waldron and Lindsay, 2006). hsdS sequence variation is localized
to the two target recognition domains (TRDs) within the gene,
with hsdS gene content shown to be lineage specific, e.g., CC30
cluster together as do CC8 strains (Cockfield et al., 2007; Lindsay,
2010).
A major advance in the understanding of staphylococcal RM
occurred with the discovery of a novel type IV restriction enzyme,
which was shown to be the dominant barrier to prevent the
uptake of foreign DNA by S. aureus (Corvaglia et al., 2010).
Mutants of hsdR in UAMS-1 (CC30) and SA564 (CC5) were not
or poorly transformable (respectively) with plasmid DNA iso-
lated from E. coli K-12 (Corvaglia et al., 2010). UV mutagenesis
of SA564hsdR− and subsequent transformation of the pooled
survivors with a shuttle plasmid from E. coli K-12 resulted in
18 transformants. The genome of the strain that exhibited the
highest transformation efficiency was sequenced along with the
parental SA564. A frameshift mutation was identified in an ORF
that has 98% identity to Sao_2790 of 8325. This gene was subse-
quently designated sauUSI (Xu et al., 2011). Disruption of sauUSI
in SA564 and UAMS-1 yielded a strain that was transformable
with the E. coli K-12-derived plasmid. Analysis of sauUSI in
RN4220 identified a nonsense mutation in the middle of the
gene and complementation using a multicopy plasmid carrying
wild-type sauUSI reduced transformation into RN4220 100-fold
(Corvaglia et al., 2010).
We have restored the sauUSI gene in the chromosome
of RN4220 to wild-type by allelic exchange which resulted
in a 10−4-fold reduction in the transformation frequency in
RN4220sauUSI+ compared to RN4220 (Monk et al., 2012). The
SauUSI protein has a very limited similarity to HsdR except for
a DNA helicase domain. Deletion of the type I RM specificity
genes hsdS1 and hsdS2 in SA564 did not yield a transformable
strain indicating that SauUSI acts independently of the type I RM
system (Corvaglia et al., 2010). The gene upstream of sauUSI in
strain Newman (called Sae_2385) encodes a protein with homol-
ogy to a nudix hydrolase that could potentially be involved in
removal of toxic nucleotide derivatives. However deletion of this
gene did not enhance transformation indicating that it is not
important for SauUSI activity (Monk et al., 2012). SauUSI is
highly conserved in S. aureus. However the CC5 strains N315
and Mu50 contain an allele of sauUSI with a nonsense mutation
within themiddle of the gene. Loss of SauUSI hasmade the strains
permissive to transformation with plasmid DNA isolated from
Enterococcus faecalis strain JH2-2 (Corvaglia et al., 2010), which
could have implications for the enhanced the spread of antibiotic
resistance between these organisms in the hospital environment
(Zhu et al., 2008). Homologues of sauUSI occur in S. epidermidis
and S. pseudintermedius and also in some enterococci, bacilli and
lactobacilli.
The biochemical properties of SauUSI were recently charac-
terized (Xu et al., 2011). The enzyme was shown to be a type
IV endonuclease. The motif recognized by SauUSI was identi-
fied as methylation of cytosine bases in the motif C/GmCNGC/G.
The E. coli K-12 strains that are widely used for cloning such as
DH5∝, TOP10, XL1-Blue and DH10B methylate both adenine
(dam) and cytosine (dcm) residues. Plasmids isolated from these
strains are readily degraded by SauUSI. In order to bypass the type
IV restriction barrier in S. aureus the plasmid must be isolated
from an E. coli strain that is defective in cytosine methylation.
DNAmethylation at cytosine residues is not only limited to E. coli.
Some type II RM systems use cytosine methylation of target sites
to prevent the activity of the cognate restriction enzyme, with
these including S. aureus lineage CC398 (Bosch et al., 2010), some
Listeria monocytogenes (Yildirim et al., 2010) and Lactococcus lactis
strains (O’Driscoll et al., 2005).
The loss of Dam methylation in E. coli leads to deregulated
mismatch repair and an elevated frequency of transition muta-
tions (Wion and Casadesus, 2006) which means that a dam
mutant is unsuitable for cloning. However a dcmmutant of E. coli
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does not have an enhanced mutation rate (Palmer and Marinus,
1994). A dcm mutant of a high efficiency cloning strain of E. coli
would be a useful host for constructing recombinant plasmids
prior to direct transformation into a wild-type SauUSI proficient
strain of S. aureus.
ELECTROPORATION OF STAPHYLOCOCCI—BYPASSING
THE RESTRICTION BARRIER
While S. aureus contains homologues of genes involved in natu-
ral competence, and induction of some of the com-like genes has
been shown upon the over expression of the comX homolog sigH
(Morikawa et al., 2003), there is no experimental evidence that
facilitated uptake of foreign DNA can occur. Electroporation is
the method of choice for introducing plasmid DNA into S. aureus
The most widely used protocol involves the growth of cells
into early logarithmic phase followed by washing with a hyper-
tonic buffer (e.g., 500mM sucrose) to remove salts and to stabilize
the cells (Augustin and Gotz, 1990; Kraemer and Iandolo, 1990;
Oskouian and Stewart, 1990; Schenk and Laddaga, 1992; Lee,
1995). The cells are concentrated to 1–3 × 1010 CFU/ml and puri-
fied plasmid DNA added. A defined electric pulse is discharged
through the cells to facilitate the uptake of the DNA. The cells are
then grown in broth for a short period of time to allow recovery
and for growth to begin prior to plating on media containing an
antibiotic that selects for the plasmid-containing transformants.
Lofblom et al. (2007) described extensive optimization of electro-
poration for Staphylococcus carnosus. Application of the final pro-
tocol with minor modifications to S. aureus strain Newman gave
a 50-fold improvement over the sucrose-wash protocol (Monk
et al., 2012) with transformants being obtained directly with DNA
isolated from E. coli K-12 strains at a low frequency (between
101 and 102 CFU/5μg plasmid DNA). In strain Newman the
restriction barriers cause a 10−4 reduction in the transformation
efficiency when comparing uptake of plasmid DNA isolated from
wild-type Newman with that isolated from E. coli K-12. Thus
improving the efficiency of electroporation allowed the type IV
and type I RM systems to be bypassed.
DC10B—A UNIVERSAL HOST FOR CONSTRUCTING
PLASMID FOR INTRODUCTION INTO STAPHYLOCOCCI
To improve the transformation of S. aureus we created an
unmarked dcm deletion mutation in the high efficiency cloning
strain E. coli DH10B to generate strain DC10B (Monk et al.,
2012). The absence of cytosine methylation allows plasmid DNA
to bypass the type IV restriction barrier. Transformation with
plasmid DNA isolated from DC10B occurred in 15 strains from
different CCs that we have so far tested. The CCs were chosen to
represent a diverse selection of S. aureus lineages and to encom-
pass the major MRSA CCs. The only strain we were unable to
transform was from CC97 (Monk et al., 2012). Using DC10B we
have been able to transform and isolate chromosomal mutations
in strains that were previously refractory to genetic manipula-
tion, for example the CC30 strains Cowan and MRSA252 (Monk
et al., 2012). The improved transformation protocol has enabled
us to transform several strains of S. lugdunensis (Heilbronner
and Foster, unpublished) and combined with DC10B has allowed
the direct transformation of S. epidermidis. For both coagulase
negative species, a reduced efficiency was found compared to
S. aureus Newman with a maximum of 103 CFU/5μg plasmid
DNA. Deletion of the sauUSI homologue (termed mcrR for
methylated cytosine recognition and restriction) in S. epidermidis
isolate RP62a (Gill et al., 2005) produced a strain that could
accept plasmid DNA from a Dcm+ E. coli K-12 host. This directly
demonstrates the importance of the type IV restriction barrier
in this species (Monk et al., 2012). In conclusion using plasmid
DNA isolated from the DC10B strain of E. coli and or an enhanced
electroporation protocol will dramatically improve our ability to
conduct genetic studies in many different staphylococci.
E. coli STRAINS THAT MODIFY PLASMID DNA FOR
STAPHYLOCOCCI
While bypassing the type IV barrier allows us to transform DNA
directly into wild-type staphylococci, the efficiency of plasmid
transfer is still low and for some applications borderline for selec-
tion (e.g., transferring pVW01ts into S. epidermidis RP62a or
direct integration of plasmids at phage att sites mediated by inte-
grase [see below]). Bypassing the type I RM barrier would require
the decoration of plasmid with the methylation pattern deter-
mined by the hsdMS genes in the strain to be transformed. There
is a paucity of information on the properties of the type I RM sys-
tems in S. aureus (Waldron and Lindsay, 2006; Sung and Lindsay,
2007). They appear to be involved in the limiting uptake of phage
DNA from unrelated staphylococci (Veiga and Pinho, 2009), play
an additive role with SauUSI in restricting foreign DNA (Monk
et al., 2012) and impede the transfer of DNA between staphy-
lococci (Corvaglia et al., 2010; Lindsay, 2010). In the simplest
system where only one hsdRMS operon is present (e.g., S. epi-
dermidis RP62a) expression of the hsdMS genes in E. coli DC10B
should further improve the efficiency of plasmid transfer. There
is a 60-fold reduction in transformation of RP62a with plas-
mid isolated from DC10B compared to RP62a isolated plasmid,
suggesting the presence of a second active RM system (unpub-
lished data). The term plasmid artificial modification (PAM) has
been coined to describe pre-methylation of plasmid DNA in an
E. coli strain which expresses the target strain’s modification and
specificity genes (Suzuki and Yasui, 2011).
Two groups have described the use of this technology for
bifidobacteria. O’Connell Motherway et al. (2009) isolated the
modification genes of a two different type II RM systems from
Bifidobacterium breve UCC2003 and expressed them either from
a plasmid or from a chromosomal locus in E. coli. An increase in
transformation by 1000-fold was observed for the plasmid-borne
methylation genes, while a 50-fold improvement was observed
for the chromosomally encoded genes compared to DNA from
the parental E. coli strain. Two type II RM methylase genes
from Bifidobacterium adolescentis were cloned into an E. coli
plasmid giving a ∼10,000-fold increase in transformation fre-
quency (Yasui et al., 2009). There is only one example of PAM
being applied to a type I RM system (Yasui et al., 2009). The
expression of the hsdMS genes of Lactococcus lactis IO-1 from a
plasmid in E. coli BL21 (DE3) yielded a seven fold improvement
in transformation.
We have constructed a strain of E. coli that expresses the func-
tional set of hsdMS genes from MRSA252 from an intergenic
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FIGURE 1 | Plasmid artificial modification—application to
staphylococci. In a cloning strain of E. coli (DH10B), the chromosome was
manipulated by recombineering to develop a host for the maximal
efficiency of plasmid transfer into the target staphylococcal strain. To
bypass the type IV restriction system, the dcm gene was deleted resulting
in a loss of cytosine methylation (red box), creating strain DC10B. Secondly,
the hsdMS genes of the target staphylococcal strain, under the control of a
strong promoter (blue box) were introduced onto the chromosome of
DC10B at a neutral site forming, for example. E. coli strain SA30B—with
hsdMS genes derived from MRSA252 (clonal complex 30). A shuttle
plasmid was isolated from each E. coli strain described above and S. aureus
MRSA252. Five micrograms of shuttle plasmid was transformed into
MRSA252 with the CFU enumerated after growth on antibiotic-containing
selective agar (bottom left table).
location in the chromosome (manuscript in preparation, Monk
and Foster) (Figure 1). Plasmid DNA isolated from SA30B
(DC10B::hsdMSMRSA252) was transformed into MRSA252 at the
same frequency as the plasmid isolated from MRSA252 with a
1000-fold improvement in transformation efficiency compared
to plasmid isolated from DC10B. We are currently introducing
the functional hsdMS genes from strains of different CC’s of
S. aureus and from different staphylococcal species into DC10B.
These hosts will be invaluable for generating plasmids for genetic
manipulation of staphylococcal strains that are currently refrac-
tory to transformation and will permit fulfillment of Molecular
Koch’s Postulates in diverse hosts.
EFFICIENT ALLELIC EXCHANGE
Several plasmids have been developed to facilitate the construc-
tion of mutations in the chromosome of staphylococci by allelic
exchange. The preferred method employs a temperature sensitive
(ts) plasmid, which replicates by the rolling circle mechanism. A
ts version of pE194 is the most widely used replicon for allelic
exchange in staphylococci (Gryczan et al., 1982). The procedure
for creating a mutation is a two-step process (Figure 2). First,
the plasmid carrying the mutational cassette is transformed into
the target strain at a temperature that is permissive for replica-
tion. Then integration by a single crossover (SCO) event at either
the upstream or downstream region of homology is selected by
growing at the non-permissive temperature for replication while
selecting for antibiotic resistance encoded by the plasmid. This
forms an integrant and creates a duplication of the locus to be
mutated with one copy being wild-type and the other copy car-
rying the mutation. Excision of the plasmid by a SCO event is
stimulated by decreasing the temperature to one permissive for
plasmid replication, in the absence of antibiotic selection. This
triggers recombination and loss of the plasmid. If the second
crossover event occurs at the region of homology used for inte-
gration the strain remains wild-type. If recombination occurs at
the opposite region of homology the mutant allele is left in the
chromosome. Excision at the same site as that used for integration
shouldoccur in theory at the same frequency as at the heterologous
site giving a mutation frequency of 50%. In practice mutation
frequencies as low as 1% (or lower) may occur (Biswas et al.,
1993; Bae and Schneewind, 2006). This canmake identification of
a mutant that lacks a selectable marker a laborious and time con-
suming process. A number of improvements to allelic exchange
have been devised for staphylococci and are detailed below.
pMAD/pORI280
A temperature sensitive shuttle plasmid was created by join-
ing pE194ts to pBR322 with the subsequent addition of a gene
encoding a constitutively expressed thermostable ß-galactosidase
(Arnaud et al., 2004). While plasmid excision cannot be selected,
colonies that lack the plasmid can be identified on plates contain-
ing X-gal where they form white colonies. A similar concept has
been applied in lactococci with the pORI280 two-plasmid system
(Leenhouts et al., 1996). A suicide plasmid missing two of the
replication genes and encoding ß-galactosidase is used for allelic
exchange, with a second ts plasmid, pVE6007 (with a pWV01ts
replicon) supplying the missing repAD encoded replication func-
tions in trans. By growth at a temperature that is restrictive for
replication pVE6007 is lost and the integrants with pORI280 in
the chromosome selected with erythromycin. Resolution of inte-
grants occurs after growth in the absence of antibiotic. We have
been unable to manipulate S. aureus using the pORI280 two-
plasmid system even though two groups have previously reported
success (Pinho and Errington, 2004; Daly et al., 2010).
pKOR1
Bae and Schneewind (2006) revolutionized the isolation of muta-
tions in S. aureus by introducing counter selection into the
procedure for allelic exchange. A secY antisense transcript which
hybridizes to mRNA encoding part of the essential Sec pro-
tein secretion system acts as an inhibitor of growth impairing
colony formation on agar. Combining tetracycline inducible secY
expression and Gateway cloning into the pTS1 ts shuttle plas-
mid (pE194ts replicon) (Greene et al., 1995) generated the vector
pKOR1 (Bae and Schneewind, 2006). The initial stages of allelic
exchange are the same as for any ts plasmid. Cells where the plas-
mid has been lost by reverse SCO can be selected directly on agar
following induction by anhydrotetracycline of secY antisense giv-
ing cells lacking pKOR1 a growth advantage. However, conditions
used for allelic exchange with pE194ts replicons can produce sec-
ondary mutations in sae, a locus which encodes a two component
signal transduction system (Sun et al., 2010). The elevated tem-
perature of growth (43◦C), aeration and low levels of antibiotic
Frontiers in Cellular and Infection Microbiology www.frontiersin.org April 2012 | Volume 2 | Article 49 | 4
Monk and Foster Genetic manipulation of Staphylococci
FIGURE 2 | Allelic exchange in staphylococci. The two-step approach
(integration/excision) is shown above for the creation of directed mutations.
A deletion construct is assembled in the multiple cloning site of a
temperature sensitive plasmid and then transformed into the target strain at
a temperature permissive for replication. A temperature shift, to one
non-permissive for plasmid replication (in the presence of selection for
antibiotic resistance encoded by the plasmid), stimulates integration through
either the up (AB—shown here) or downstream (CD) region of cloned
homologous DNA. Decreasing the temperature and removing antibiotic
selection stimulates rolling circle replication which leads to vector excision.
As described in the text, the different allelic exchange plasmids developed for
staphylococci contain additional features which aid in discrimination of
colonies lacking the plasmid either post excision, e.g., (a) pMAD: constitutive
bgaB for the hydrolysis of the colourmetric substrate—detected as white
colonies on X-gal containing agar, (b) pKOR1/pIMAY: ATc inducible secY
antisense to repress growth of plasmid-containing strains or (c) I-SceI
induced double strained DNA breaks (DSB) which promote homologous
recombination.
resistance expressed by the plasmid’s chloramphenicol resistance
determinant, particularly when at a single copy in the chromo-
some, can promote the selection of sae mutations. sae mutations
can influence the expression of other genes and alter virulence
(Herbert et al., 2010).
pIMAY
To alleviate problems associated with using pKOR1 we have con-
structed a plasmid vector for allele exchange that has a strongly
expressed drug resistance marker and a ts replicon that allows
selection of integrants at 37◦C (Monk et al., 2012). The pVWO1ts
replicon on pIMAY is functional in staphylococci (S. aureus,
S. epidermidis and S. lugdunenesis have so far been tested) at
the permissive temperature (30◦C) but the plasmid cannot repli-
cate at the restrictive temperature of 37◦C. The replicon used
to propagate the plasmid in E. coli is low copy number which
should improve the stability of cloned staphylococcal DNA. The
chloramphenicol resistance (cat) gene is expressed from a strong
promoter which allows efficient selection as a single copy when
integrated into the staphylococcal chromosome. The plasmid car-
ries the inducible secY antisense counterselection determinant of
pKOR1. Furthermore, we have recently applied a sequence- and
ligation-independent cloning (Li and Elledge, 2007) to pIMAY
which increases the cloning efficiency (greater than 90% of
colonies screened contain inserts) and reduces the costs and time
involved in production of deletion constructs. From the start of
cloning to mutant confirmation can be conducted in under two
weeks (Monk et al., 2012).
I-SceI
Counter selection with secY enriches for cells which have lost the
integrated plasmid following the second SCO event. However,
enhancing the rate of plasmid excision requires initiating DNA
replication at the integrated plasmid’s origin. An alternative
approach utilizes a rare cutting restriction enzyme SceI which rec-
ognizes an 18 bp sequence yet to be found in bacteria (Posfai et al.,
1999). It was first shown in mammalian cells that the induction
of double stranded DNA breaks (DSBs) following expression of
SceI induced homologous recombination (Choulika et al., 1995).
After codon optimization of sceI the enzyme was applied to sev-
eral Gram-negative andGram-positive bacteria (Janes and Stibitz,
2006; Szurmant et al., 2007; Flannagan et al., 2008; Blank et al.,
2011; Martinez-Garcia and de Lorenzo, 2011). Pagels et al. (2010)
developed the SceI system for use in S. aureus.The allelic exchange
plasmid with the pE194ts replicon carries the SceI restriction
cleavage site (pJM930). After integration into the chromosome by
SCO at the locus to be deleted, a second plasmid (pJM928) with
a compatible pT181ts replicon constitutively expressing SceI was
delivered by transduction. The enzyme introduces a DSB within
the integrated plasmid. This induces homologous recombination
which promotes plasmid excision, which in other bacteria has
increased the frequency of wild-type to mutant up to 50% (Posfai
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et al., 1999; Janes and Stibitz, 2006). Cells where the plasmid has
been excised will not have a DNA break in the chromosome while
the excised plasmid carrying the cleavage site will be destroyed.
This approach should dramatically improve the efficiency of gen-
erating mutations. Ideally an inducible sceI gene should be part
of the mutational plasmid to avoid the need to use a second plas-
mid, but this will require a very strong repressor to prevent SceI
expression during plasmid propagation and integration.
TEMPERATURE—AN IMPORTANT CONSIDERATION
A recent publication has identified sequential non-selective pas-
sage at a reduced temperature (25◦C) as a method to improve the
frequency of co-integrate resolution (Kato and Sugai, 2011). Their
results also highlighted the requirement for the isolation of both
SCOs, either through the up or downstream region of homology.
We have found that resuspension of a colony and direct plating
rather than broth growth at the non-permissive temperature for
plasmid replication improves the isolation of both SCOs (Monk
et al., 2012). Combining the DC10B strain with pIMAY or other ts
plasmids will enhance isolation of mutations in laboratory strains
and diverse clinical isolates.
VALIDATION OF MUTATIONS BY COMPLEMENTATION
After construction of a mutant, any change in phenotype should
be corroborated by complementation in order to prevent attribut-
ing properties to the missing gene that are actually due to
secondary mutations. Currently four approaches to complemen-
tation can be applied.
SHUTTLE PLASMIDS
A number of shuttle plasmids that replicate both in E. coli and
staphylococci have been constructed that utilize several differ-
ent plasmid replicons (pE194, pC194, pT181, pKS1). The effect
of plasmid copy number should be considered when attempt-
ing to complement a mutation. A gene-dosage effect may lead
to high level expression which could potentially be toxic. This
could be reduced by using an inducible gene expression system
(see below). Plasmid-based complementation can be established
quickly compared to other methods. However it can be diffi-
cult to use in animal infection experiments where the plasmid is
often lost in the absence of antibiotic selection in vivo (Cho et al.,
2011). It is possible to maintain selection by administering antibi-
otics into drinking water but this is not ideal (de Azavedo et al.,
1985; BubeckWardenburg et al., 2006). For an extensive review of
plasmids used in staphylococcal research see McNamara (2008).
INDUCIBLE GENE EXPRESSION
Promoters that can be activated by the inducers IPTG (Zhang
et al., 2000), xylose (Peschel et al., 1996), cadmium (Charpentier
et al., 2004) and anhydrotetracycline (ATc) (Bateman et al.,
2001) have been used in staphylococci. The ATc inducible vector
pRMC2 was derived from pALC2073 (Bateman et al., 2001) by
increasing the level of expression of the TetR repressor to reduce
leakiness (Corrigan and Foster, 2009). Recently the laboratory of
R. Bertram has constructed and validated a series of improved
ATc inducible expression vectors that were derived from pRMC2.
By inserting a second tetO binding site for TetR downstream of
the −10 box of the Pxyl/tet promoter, creating pRAB11, a greater
level of repression compared to that of pRMC2 was observed
(Helle et al., 2011). Mutations in the –10 and –35 boxes of the
Pxyl/tet promoter in pRAB11 resulted in reduced expression, but
achieved a higher level of repression. Finally, a hybrid tetR gene
(tetR-BD) improved both the level of expression when induced
and the level of repression when uninduced compared to pRAB11
while introduction revtetR (reverse tetR—contains 3 amino acid
changes which reverse the activity of TetR) yielded a construct
comparable to pRAB11, except exhibiting repression in the pres-
ence of ATc but induction in the absence (Helle et al., 2011).
These vectors should be of great value for experiments requiring
controlled expression of a cloned gene in vitro.
PHAGE INTEGRASE VECTORS
Integrating vectors that utilize the att sites and integrases of
lysogenic phages have been developed to eliminate the prob-
lems associated with complementation by extrachromosomally
replicating plasmids. These allow the integration of a plasmid
at a specific phage attachment site in the chromosome directed
by a phage integrase (van Mellaert et al., 1998; Haldimann and
Wanner, 2001; Lauer et al., 2002; Huff et al., 2010). The integrated
plasmid lacks a replicon that functions in S. aureus and is stable
even in the absence of selective antibiotic. The presence of only a
single copy of the plasmid eliminates gene-dosage effects.
The pLL39 phage integrase vector encodes both φL54a and
φ11 attP sites and in the presence of the appropriate phage inte-
grase can insert into the matching chromosomal attB site (Luong
and Lee, 2007). This vector is a refinement of the previously devel-
oped and successfully applied pCL83/pCL84 vectors (Lee et al.,
1991). To stimulate pLL39 integration, the integrase is encoded
on a second extrachromosomally replicating plasmid (Luong and
Lee, 2007). Similar two plasmid systems have been created based
on the phage related S. aureus pathogenicity island (SaPI1) using
the SaPI1 int and attS to direct integration (Charpentier et al.,
2004). However until now both pLL39 and the SaPI1 based vector
system could only be integrated into the chromosome of RN4220
and must then be moved by generalized transduction into the
target strain. Transduction from RN4220 can be problematic
because DNA that is located adjacent to the integrated plasmid
will also be introduced by the double reciprocal recombination
event. This could introduce mutations into the recipient. Also
transfer is limited to strains that are closely related to RN4220,
similar to plasmid transformation discussed earlier, due to RM.
It is also possible that the integration of the plasmid itself could
cause a change in virulence of the host. It is of note that the
φL54a attB site is located within the geh gene which encodes an
extracellular lipase (Lee and Iandolo, 1985). Although this could
be controlled for by comparing the complemented mutant strain
with the mutant carrying the empty vector, the ideal integrating
vector would insert into an attB site that is located in an intergenic
region. Lei et al. (2012) recently constructed a phage integrase
vector, which recognizes an engineered core attB sequence based
on the φL54a. This synthetic attB sequence was inserted onto the
chromosome of RN4220 at a region characterized with negligible
transcriptional activity and allowed the transformation with the
attP compatible vector (pLL102). The region is highly conserved
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among S. aureus isolates which should allow the transfer either by
phage transduction or by direct electroporation.
We are currently testing two new small (∼3 kb) phage inte-
grase vectors that incorporate phage φ11 or φ80 attP sites as well
as the appropriate integrase gene. The plasmids can be propa-
gated in E. coli DC10B and transformed directly into the wild
type S. aureus strain where they will integrate under the direction
of the encoded integrase. This eliminates the need for a second
plasmid encoding the integrase and improves the efficiency of the
process (Monk, Tan, Shah and Foster, unpublished).
GENE RECONSTITUTION
Sometimes genes cloned into multicopy plasmids can be toxic to
E. coli or the target strain (Pilgrim et al., 2003; Alonzo et al., 2011),
expression from a phage integrase vector may occur at a differ-
ent level compared to wild-type despite the presence of the native
promoter (Lauer et al., 2002) or polar effects may need to be ruled
out. Reconstitution of the mutated gene to wild-type (Donegan
and Cheung, 2009; Diep et al., 2010; Monk et al., 2012) by reverse
allelic exchange can be employed. The wild-type gene and flank-
ing DNA are cloned into a ts allelic exchange-promoting plasmid
such as pIMAY. A codon change that creates a novel restriction site
without altering the amino acid sequence of the encoded protein
(http://emboss.bioinformatics.nl/cgi-bin/emboss/silent) is intro-
duced to facilitate identification of the restored gene. This is time
consuming but results in a complemented strain that differs from
wild-type only by the introduced restriction site.
CONCLUSIONS AND FUTURE PERSPECTIVES
In this article we have described a genetic toolbox that is appli-
cable to many species of Staphylococcus and we have reviewed
how recent developments in understanding of RM systems have
greatly improved the ability to manipulate these bacteria geneti-
cally. Bypassing the host encoded RM systems with plasmid DNA
isolated from E. coli DC10B expressing staphylococcal HsdMS
proteins will enable the rapid construction of mutant strains by
allelic exchange and for their complementation.
S. epidermidis strains are much more difficult to work with
than S. aureus because they are transformable by electroporation
at a much lower frequency. Wall teichoic acid has recently
been identified as a barrier to transformation in S. epidermidis
(Holland et al., 2011). Optimization of conditions for generat-
ing competent cells for electroporation (Lofblom et al., 2007)
will be required to increase the frequency of transformation.
Development of a single plasmid phage integrase vector for S. epi-
dermidis would require enhanced transformation.
To take advantage of the high transformation efficiencies that
can be achieved in S. aureus, we propose to apply single stranded
DNA recombineering where point mutations, small insertions
or deletions can be rapidly constructed in chromosomal genes
(Swingle et al., 2010). This technology has been used E. coli,
Shigella flexneri, Salmonella typhimurium, Pseudomonas syringae
(Swingle et al., 2010), Mycobacteria (van Kessel and Hatfull,
2008) and more recently to lactic acid bacteria (van Pijkeren
and Britton, 2012). Expression of the recT-encoded single strand
DNA annealing protein enhances the incorporation of synthetic
oligonucleotides designed to bypass the mismatch repair pathway.
We have identified several recT homologues that are functional in
S. aureus and are currently optimizing the procedure (Monk, van
Pijkeren, Britton and Foster, unpublished).
Through mining staphylococcal genome sequences, we have
observed that both the type I and/or type IV systems are highly
conserved in staphylococci. However, some strains (e.g., S. aureus
RF122, Cowan, JKD6159 and S. pseudintermedius ED99) encode
additional type I or II RM systems, which can impair transfor-
mation (unpublished data). The type IV restriction system can be
by-passed using plasmid that lacks cytosine methylation while a
type I or a type II system bypass would require the plasmid obtain
the methylation profile of the specific RM system.
In summary the improvements in vectors and transforma-
tion described above has facilitated genetic manipulation in many
strains of S. aureus and other staphylococcal species which were
previously not amenable to transformation with plasmid DNA
(Monk et al., 2012). Also the time taken to construct strains and
to perform genetic manipulation has been reduced significantly.
This will facilitate more sophisticated genetic manipulation in
clinically relevant strains and will contribute directly to rapid
advances in knowledge about this important group of organisms
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